Literature DB >> 3997064

Effects of dopamine receptor stimulation on opiate-induced modifications of pituitary-gonadal function.

P P Vescovi, A Pezzarossa, G Ceresini, G Rastelli, G Valenti, G Gerra.   

Abstract

We evaluated the effects of the dopaminergic drug bromocriptine (Br) on prolactin (PRL), luteinizing hormone (LH) and testosterone (Te) levels in a homogeneous group of opiate addicts in a methadone maintenance program (20 mg twice daily). Basal blood levels of PRL, LH and Te were determined in 15 adult male drug addicts, before 30 and 60 days after Br administration (7.5 mg/day) was started. 15 healthy volunteers served as controls for the evaluation of basal values of the hormones. Before treatment PRL values were high, while LH and Te levels were lower than normal. 30 days later, PRL lowered significantly while LH and Te increased significantly. 60 days later, the blood hormone values were still significantly different from pretreatment values, and close to the normal range. This observation shows that Br, probably through an increase of dopaminergic tone, may counteract some effects of opiates on the hypothalamic-pituitary-gonadal axis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3997064     DOI: 10.1159/000180040

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  3 in total

Review 1.  The effects of opioids and opioid analogs on animal and human endocrine systems.

Authors:  Cassidy Vuong; Stan H M Van Uum; Laura E O'Dell; Kabirullah Lutfy; Theodore C Friedman
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

Review 2.  Opioids and pituitary function: expert opinion.

Authors:  Mônica R Gadelha; Niki Karavitaki; Jeffrey Fudin; Jeffrey J Bettinger; Hershel Raff; Anat Ben-Shlomo
Journal:  Pituitary       Date:  2022-01-23       Impact factor: 4.107

3.  Effect of the co-administration of glucose with morphine on glucoregulatory hormones and causing of diabetes mellitus in rats.

Authors:  Maryam Radahmadi; Mohammad Reza Sharifi; Masoud Amini; Mehrafarin Fesharaki
Journal:  Adv Biomed Res       Date:  2016-02-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.